About Biotie
Biotie is a company based in Turku (Finland) founded in 1998 was acquired by Acorda in January 2016.. Biotie has raised $149.81 million across 4 funding rounds from investors including Acorda and The Baupost Group. The company has 27 employees as of December 31, 2022. Biotie has completed 2 acquisitions, including Elbion and Synosia Therapeutics. Biotie operates in a competitive market with competitors including Indivior, Ethypharm, Braeburn, Amygdala Neurosciences and Cessation Therapeutics, among others.
- Headquarter Turku, Finland
- Employees 27 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biotie
Biotie has successfully raised a total of $149.81M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(11 Jun 2013)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2015 | Amount | Post-IPO - Biotie | Valuation |
investors |
|
| May, 2015 | Amount | Series D - Biotie | Valuation |
investors |
|
| Jul, 2014 | Amount | Grant - Biotie | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biotie
Biotie has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Acorda and The Baupost Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Conducts long-term value-oriented investments for families, foundations, and institutions.
|
Founded Year | Domain | Location | |
|
Engaged in the development and commercialization of therapies that improve neurological function.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biotie
Biotie has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Elbion and Synosia Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutics for CNS disorders including Parkinson's are developed.
|
2005 | ||||
|
Small molecules for CNS and inflammatory diseases were discovered.
|
2002 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Biotie
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biotie Comparisons
Competitors of Biotie
Biotie operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indivior, Ethypharm, Braeburn, Amygdala Neurosciences and Cessation Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for opioid addiction treatment are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Therapies for pain and addiction treatment are developed.
|
|
| domain | founded_year | HQ Location |
Long-acting therapies for opioid addiction and chronic pain are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for substance use disorders are developed by Amygdala Neurosciences.
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapy based vaccines to manage addictions
|
|
| domain | founded_year | HQ Location |
Developer of small molecule drugs targeting CB1 receptor for CNS diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biotie
Frequently Asked Questions about Biotie
When was Biotie founded?
Biotie was founded in 1998 and raised its 1st funding round 15 years after it was founded.
Where is Biotie located?
Biotie is headquartered in Turku, Finland. It is registered at Turku, Varsinais-suomi, Finland.
Who is the current CEO of Biotie?
Jari Saarinen is the current CEO of Biotie.
Is Biotie a funded company?
Biotie is a funded company, having raised a total of $149.81M across 4 funding rounds to date. The company's 1st funding round was a Grant of $2M, raised on Jun 11, 2013.
How many employees does Biotie have?
As of Dec 31, 2022, the latest employee count at Biotie is 27.
What does Biotie do?
Biotie was founded in 1998 in Turku, Finland, as a biotech firm specializing in drug development for central nervous system disorders. Operations center on advancing treatments for neurodegenerative and psychiatric conditions, including Selincro for alcohol dependency, which is marketed in Europe by H. Lundbeck AS, and Tozadenant, now entering Phase 3 trials for Parkinsons disease. The company operates in the commercial stage of biotechnology.
Who are the top competitors of Biotie?
Biotie's top competitors include Indivior, Ethypharm and Amygdala Neurosciences.
How many acquisitions has Biotie made?
Biotie has made 2 acquisitions, including Elbion, and Synosia Therapeutics.
Who are Biotie's investors?
Biotie has 2 investors. Key investors include Acorda, and The Baupost Group.